Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Optimizing Systemic Therapy for Chronic Lymphocytic Leukemia
EP. 1: First-Line Therapy for Older Patients With CLL
January 4th 2019
EP. 2: Ibrutinib Versus FCR for Younger Patients With CLL
January 4th 2019
EP. 3: Novel Combination Therapies for CLL
January 4th 2019
EP. 4: Prognostic Factors in CLL
January 4th 2019
EP. 5: Emerging BTK Inhibitors for CLL
January 4th 2019
EP. 6: Real-World Data for CLL
January 4th 2019
EP. 7: Venetoclax + Rituximab in Relapsed CLL
January 4th 2019
EP. 8: Toxicity Management With Venetoclax for CLL
January 4th 2019
EP. 9: CD20-Targeted Antibodies With Novel Agents for CLL
January 4th 2019
EP. 10: Resistance to Venetoclax in CLL
January 4th 2019
EP. 11: Resistance to Ibrutinib in CLL
January 4th 2019
EP. 12: Duvelisib for Relapsed/Refractory CLL
January 4th 2019
EP. 13: CAR T-Cell Therapy for CLL
January 4th 2019
EP. 14: Take-Home Messages From ASH 2018 in CLL
January 4th 2019
EP. 15: Standardizing MRD Testing for CLL
January 4th 2019